• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默型老年痴呆症中的促肾上腺皮质激素释放因子样免疫反应性。皮质和纹状体浓度降低。

Corticotropin-releasing factor-like immunoreactivity in senile dementia of the Alzheimer type. Reduced cortical and striatal concentrations.

作者信息

Bissette G, Reynolds G P, Kilts C D, Widerlöv E, Nemeroff C B

出版信息

JAMA. 1985 Dec 6;254(21):3067-9.

PMID:3877182
Abstract

The concentration of corticotropin-releasing factor-like immunoreactivity (CRF-LI) in the human central nervous system was measured by radioimmunoassay in postmortem tissue of control patients and in those with histologically confirmed senile dementia of the Alzheimer type (SDAT). In the controls, CRF-LI was found in high concentrations in the hypothalamus and frontal cortex (Brodmann's area 10), in moderate concentrations in amygdala, substantia innominata, temporal and parietal cortex (Brodmann's areas 38 and 7), and the caudate nucleus, and in low concentrations in posterior hippocampus and nucleus accumbens. A marked reduction in the concentration of CRF-LI was observed in the frontal and temporal cortex (approximately 50%) as well as in the caudate nucleus (approximately 70%) in the SDAT group. The present findings suggest that neurons containing corticotropin-releasing factor are pathologically altered in SDAT, in addition to the previously described cholinergic and somatostatinergic neuronal degeneration.

摘要

采用放射免疫分析法,测定了对照患者及经组织学确诊为阿尔茨海默型老年性痴呆(SDAT)患者死后脑组织中促肾上腺皮质激素释放因子样免疫反应性物质(CRF-LI)的浓度。在对照组中,下丘脑和额叶皮质(布罗德曼第10区)的CRF-LI浓度较高,杏仁核、无名质、颞叶和顶叶皮质(布罗德曼第38区和第7区)以及尾状核中的浓度中等,而后海马和伏隔核中的浓度较低。在SDAT组中,额叶和颞叶皮质(约50%)以及尾状核(约70%)的CRF-LI浓度显著降低。目前的研究结果表明,除了先前描述的胆碱能和生长抑素能神经元变性外,含促肾上腺皮质激素释放因子的神经元在SDAT中也发生了病理改变。

相似文献

1
Corticotropin-releasing factor-like immunoreactivity in senile dementia of the Alzheimer type. Reduced cortical and striatal concentrations.阿尔茨海默型老年痴呆症中的促肾上腺皮质激素释放因子样免疫反应性。皮质和纹状体浓度降低。
JAMA. 1985 Dec 6;254(21):3067-9.
2
[CRF-like immunoreactivities in mammalian brains examined with a radioimmunoassay for CRF].[用促肾上腺皮质激素释放因子放射免疫分析法检测哺乳动物大脑中促肾上腺皮质激素释放因子样免疫反应性]
Yakubutsu Seishin Kodo. 1986 Jun;6(2):253-8.
3
Neuropeptides in Alzheimer's disease: a postmortem study.阿尔茨海默病中的神经肽:一项尸检研究。
Regul Pept. 1989 Apr;25(1):123-30. doi: 10.1016/0167-0115(89)90254-1.
4
Reciprocal changes in corticotropin-releasing factor (CRF)-like immunoreactivity and CRF receptors in cerebral cortex of Alzheimer's disease.阿尔茨海默病大脑皮质中促肾上腺皮质激素释放因子(CRF)样免疫反应性和CRF受体的相互变化。
Nature. 1986;319(6054):593-5. doi: 10.1038/319593a0.
5
Neurotensin immunoreactivity in post-mortem brain is increased in Down's syndrome but not in Alzheimer-type dementia.唐氏综合征患者尸检大脑中的神经降压素免疫反应性增加,但阿尔茨海默病型痴呆患者则不然。
J Neurol Sci. 1985 Mar;67(3):327-35. doi: 10.1016/0022-510x(85)90157-1.
6
Cortical concentrations of corticotropin-releasing hormone and its receptor in Alzheimer type dementia and major depression.
Biol Psychiatry. 1990 Oct 1;28(7):603-8. doi: 10.1016/0006-3223(90)90398-l.
7
Brain histamine in Alzheimer's disease.阿尔茨海默病中的脑组胺。
Methods Find Exp Clin Pharmacol. 1989 May;11(5):353-60.
8
Neocortical concentrations of neuropeptides in senile dementia of the Alzheimer and Lewy body type: comparison with Parkinson's disease and severity correlations.
Biol Psychiatry. 1991 Feb 15;29(4):357-64. doi: 10.1016/0006-3223(91)90221-7.
9
Somatostatin immunoreactivity in cortical and some subcortical regions in Alzheimer's disease.阿尔茨海默病中皮质及部分皮质下区域的生长抑素免疫反应性
J Neurol Sci. 1985 Dec;71(2-3):315-23. doi: 10.1016/0022-510x(85)90070-x.
10
Time-dependent alterations in corticotropin-releasing factor-like immunoreactivity in different brain regions after acute cocaine administration to rats.给大鼠急性注射可卡因后不同脑区促肾上腺皮质激素释放因子样免疫反应性的时间依赖性变化
Neuropeptides. 1997 Feb;31(1):15-8. doi: 10.1016/s0143-4179(97)90013-5.

引用本文的文献

1
Dissecting the shared genetic architecture between Alzheimer's disease and frailty: a cross-trait meta-analyses of genome-wide association studies.剖析阿尔茨海默病与衰弱之间的共享遗传结构:全基因组关联研究的跨性状荟萃分析。
Front Genet. 2024 Apr 19;15:1376050. doi: 10.3389/fgene.2024.1376050. eCollection 2024.
2
Discovering new peripheral plasma biomarkers to identify cognitive decline in type 2 diabetes.发现用于识别2型糖尿病认知功能减退的新型外周血生物标志物。
Front Cell Dev Biol. 2022 Nov 24;10:818141. doi: 10.3389/fcell.2022.818141. eCollection 2022.
3
Corticotropin releasing factor-binding protein (CRF-BP) as a potential new therapeutic target in Alzheimer's disease and stress disorders.
促肾上腺皮质素释放因子结合蛋白(CRF-BP)作为阿尔茨海默病和应激障碍的潜在新治疗靶点。
Transl Psychiatry. 2019 Oct 22;9(1):272. doi: 10.1038/s41398-019-0581-8.
4
Metabolic and Non-Cognitive Manifestations of Alzheimer's Disease: The Hypothalamus as Both Culprit and Target of Pathology.阿尔茨海默病的代谢和非认知表现:下丘脑作为病理的罪魁祸首和靶点
Cell Metab. 2015 Nov 3;22(5):761-76. doi: 10.1016/j.cmet.2015.08.016. Epub 2015 Sep 10.
5
An anxiolytic role for CRF receptor type 1 in the globus pallidus.CRF 受体 1 在苍白球中发挥抗焦虑作用。
J Neurosci. 2011 Nov 30;31(48):17416-24. doi: 10.1523/JNEUROSCI.3087-11.2011.
6
The role of G protein-coupled receptors in the pathology of Alzheimer's disease.G 蛋白偶联受体在阿尔茨海默病病理中的作用。
Nat Rev Neurosci. 2011 Feb;12(2):73-87. doi: 10.1038/nrn2977.
7
Chemical modification of class II G protein-coupled receptor ligands: frontiers in the development of peptide analogs as neuroendocrine pharmacological therapies.化学修饰 II 类 G 蛋白偶联受体配体:开发作为神经内分泌药理学治疗的肽类似物的前沿。
Pharmacol Ther. 2010 Jan;125(1):39-54. doi: 10.1016/j.pharmthera.2009.07.006. Epub 2009 Aug 15.
8
Effects of stress and stress hormones on amyloid-beta protein and plaque deposition.应激及应激激素对β-淀粉样蛋白和斑块沉积的影响。
J Alzheimers Dis. 2009;18(2):459-69. doi: 10.3233/JAD-2009-1152.
9
Synaptic physiology of central CRH system.中枢促肾上腺皮质激素释放激素系统的突触生理学
Eur J Pharmacol. 2008 Apr 7;583(2-3):215-25. doi: 10.1016/j.ejphar.2007.11.075. Epub 2008 Feb 1.
10
Longitudinal brain corticotropin releasing factor and somatostatin in a transgenic mouse (TG2576) model of Alzheimer's disease.阿尔茨海默病转基因小鼠(TG2576)模型中脑内促肾上腺皮质激素释放因子和生长抑素的纵向研究
J Alzheimers Dis. 2007 Sep;12(2):115-27. doi: 10.3233/jad-2007-12201.